Rob Faulkner - Profile and Investment Details

Investor Profile

Rob Faulkner is a Hedge Fund, Venture Capital, Private Equity Firm based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical, Nightstar Therapeutics, Attenua, Syros Pharmaceuticals, Science 37, Evox Therapeutics, Zentalis Pharmaceuticals, Redx Pharma, Jounce Therapeutics, Aprea, Wave Life Sciences, Atea Pharmaceuticals, Xeris Pharmaceuticals, Inc., IGM BiosciencesGenalyte, AbSci, Sonendo, Nuvation Bio, ADC Therapeutics, Entrada Therapeutics, Saluda Medical, Hookipa Pharma, immatics biotechnologies, inui Health, CytomX Therapeutics, Audentes Therapeutics, MedAvail Technologies Inc./MedAvail Technologies US Inc., BioNTech, Yumanity Therapeutics, Cabaletta Bio, JMP Securities, Kymera Therapeutics, Scioderm, Ovid Therapeutics, ArcherDX, Xeris Pharmaceuticals, ElevateBio, Sphere Fluidics Limited, Stoke Therapeutics, Verve Therapeutics, Array BioPharma, SomaLogic, Augmedix, Akero Therapeutics, Afferent Pharmaceuticals, Impulse Dynamics, RayzeBio, Repare Therapeutics, Allakos, Replimune Group, Atreca, Genalyte, Inc., Neuron23, AlloVir, First Aid Shot Therapy, Scholar Rock, Pliant Therapeutics, Clear Labs, Amunix, Escient Pharmaceuticals, MedAvail, True North Therapeutics, Call9, Achilles Therapeutics, TCR2, Gritstone Oncology, Thomas Weisel Partners, Annexon Biosciences, JPMorgan (Hambrecht & Quist), Lava Therapeutics, aTyr Pharma, Alder Biopharmaceuticals, Beam Therapeutics, Lantern, Ayala Pharmaceuticals, Virta Health, Nurix Therapeutics, Vapotherm, AgomAb Therapeutics, Deciphera Pharmaceuticals, Shattuck Labs, Neurogene, . Over time, Rob Faulkner has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Rob Faulkner is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Women Founded, Life Science, Robotics, Software, Biotechnology, Genomics, Health Diagnostics, Developer Tools, Medical, Therapeutics, Machine Learning, Emergency Medicine, Pharmaceuticals may find it worthwhile to explore potential connections with Rob Faulkner, as their portfolio suggests a familiarity and interest in this area.

Understanding Rob Faulkner’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.